Researchers studying the serum of patients with osteoporosis found that Jintiange capsules inhibited the κB inhibitor signaling pathway by downregulating the overexpression of osteopontin, ultimately reducing MMP-3 expression. The gene discussed is MMP3; the disease is osteoporosis.